trending Market Intelligence /marketintelligence/en/news-insights/trending/2wqZK7RQgG3E3tp4JQHijw2 content esgSubNav
In This List

ChenGuang Biotech swings to loss in Q1

Podcast

Next in Tech | Episode 50: InfoSec spending up, again…

Blog

Broadcast deal market recap 2021

Podcast

Next in Tech | Episode 49: Carbon reduction in cloud

Blog

Price wars in India: Disney+ Hotstar vs. Amazon Prime Video vs. Netflix


ChenGuang Biotech swings to loss in Q1

4915618 said its normalized net income for the first quarter was a loss of 78,880 yuan, compared with income of 3.2 million yuan in the year-earlier period.

Normalized net income excludes unusual gains or losses on a pre- and after-tax basis.

The normalized profit margin declined to 0.7% from 1.1% in the year-earlier period.

Total revenue came to 278.5 million yuan, compared with 280.3 million yuan in the prior-year period, and total operating expenses totaled 275.6 million yuan, compared with 273.2 million yuan in the year-earlier period.

eported net income rose 29.5% on an annual b ChenGuang Biotech Group Co. Ltd..